Tempus AI, Inc. $TEM Shares Newly Purchased by Mirae Asset Global Investments Co. Ltd.

Key Points

• Mirae Asset Global Investments initiated a position in Tempus AI during the third quarter, buying 65,114 shares worth about $5.33 million. Institutional investors and hedge funds own 24.22% of the stock.
• Tempus AI beat quarterly expectations, reporting EPS of $0.07 versus estimates of a $0.09 loss and revenue of $411.54 million, up 23.1% year over year.
• Analyst views are mixed: the consensus rating is “Hold,” with a $79.37 average price target. Shares opened at $70.43 after a reported 6.9% decline, while company insiders have sold shares recently.

Mirae Asset Global Investments Co. Ltd. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 65,114 shares of the company's stock, valued at approximately $5,333,000.

A number of other hedge funds have also recently made changes to their positions in the company. ProShare Advisors LLC raised its holdings in Tempus AI by 5.9% in the 3rd quarter. ProShare Advisors LLC now owns 6,500 shares of the company's stock valued at $532,000 after buying an additional 360 shares during the last quarter. Vise Technologies Inc. acquired a new stake in Tempus AI during the 3rd quarter worth approximately $235,000. International Assets Investment Management LLC boosted its position in Tempus AI by 3,027.6% during the 3rd quarter. International Assets Investment Management LLC now owns 104,555 shares of the company's stock worth $8,563,000 after buying an additional 101,212 shares during the period. Partners Wealth Management LLC bought a new stake in Tempus AI during the 3rd quarter worth approximately $241,000. Finally, China Universal Asset Management Co. Ltd. grew its holdings in Tempus AI by 15.2% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 32,002 shares of the company's stock worth $2,643,000 after acquiring an additional 4,227 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TEM has been the subject of several recent research reports. UBS Group assumed coverage on shares of Tempus AI in a research report on Wednesday, September 9th. They issued a "neutral" rating and a $70.00 price target for the company. Roth Capital assumed coverage on shares of Tempus AI in a research note on Tuesday, September 8th. They set a "neutral" rating and a $67.00 price target for the company. Needham & Company LLC lifted their price target on shares of Tempus AI from $75.00 to $89.00 and gave the stock a "buy" rating in a report on Monday. BTIG Research boosted their price objective on shares of Tempus AI from $80.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday. Finally, HC Wainwright boosted their price objective on shares of Tempus AI from $68.00 to $85.00 and gave the stock a "buy" rating in a research note on Tuesday. Eleven research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $79.37.

Tempus AI Trading Down 6.9%

Shares of TEM stock opened at $70.43 on Friday. Tempus AI, Inc. has a 1-year low of $40.77 and a 1-year high of $89.09. The company has a current ratio of 2.61, a quick ratio of 3.16 and a debt-to-equity ratio of 2.70. The stock has a market cap of $12.71 billion, a price-to-earnings ratio of -66.44 and a beta of 3.61. The stock has a 50-day moving average of $71.21 and a 200-day moving average of $57.20.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.16. Tempus AI had a negative return on equity of 47.00% and a negative net margin of 12.54%. The company had revenue of $411.54 million for the quarter, compared to analyst estimates of $409.39 million. During the same period in the previous year, the firm earned ($0.46) earnings per share. The firm's quarterly revenue was up 23.1% on a year-over-year basis. On average, equities research analysts forecast that Tempus AI, Inc. will post -1.45 earnings per share for the current year.

Insider Activity

In other news, CEO Eric P. Lefkofsky sold 250,000 shares of the company's stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $77.47, for a total value of $19,367,500.00. Following the sale, the chief executive officer directly owned 100,000 shares of the company's stock, valued at approximately $7,747,000. This represents a 71.43% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Ryan Fukushima sold 41,095 shares of the company's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $49.61, for a total transaction of $2,038,722.95. Following the completion of the sale, the chief executive officer directly owned 562,463 shares in the company, valued at approximately $27,903,789.43. This represents a 6.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,237,227 shares of company stock worth $85,388,983 in the last 90 days. 24.26% of the stock is owned by company insiders.

Tempus AI News Roundup

Here are the key news stories impacting Tempus AI this week:

• Positive Sentiment: Cantor Fitzgerald maintained its Buy rating, while HC Wainwright and Robert W. Baird were also reported to see strong potential appreciation. These recommendations may support investor confidence. Cantor Fitzgerald maintains Buy rating HC Wainwright forecast Baird forecast
• Positive Sentiment: Recent results were stronger than expected: Tempus reported quarterly revenue of $411.5 million, up 23.1% year over year, and earnings per share of $0.07 versus analysts’ forecast for a loss. The beat provides a favorable business-performance backdrop. Tempus AI earnings beat
• Negative Sentiment: CEO Ryan Fukushima sold 80 shares and director David Epstein sold 370 shares at $74.29. Both trades were executed under pre-arranged Rule 10b5-1 plans, and the small sales leave their substantial holdings largely intact, tempering the potential concern. Director stock sale disclosure

About Tempus AI

Tempus AI, Inc is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies.

Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.